$Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction$

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction

Background: Indications for the primary prevention of sudden death using an implantable cardioverter defibrillator (ICD) are based predominantly on left ventricular ejection fraction (LVEF). However, right ventricular ejection fraction (RVEF) is also a known prognostic factor in a variety of structu...

Full description

Bibliographic Details
Main Authors:	Laura Jimenez-Juan, MD, Gauri R. Karur, MD, Kim A. Connelly, MD, PhD, Djeven Deva, MD, Raymond T. Yan, MD, Rachel M. Wald, MD, Sheldon Singh, MD, General Leung, PhD, Anastasia Oikonomou, MD, PhD, Paul Dorian, MD, Paul Angaran, MD, Andrew T. Yan, MD
Format:	Article
Language:	English
Published:	Wiley 2017-04-01
Series:	Journal of Arrhythmia
Subjects:	Implantable cardioverter defibrillator Cardiac magnetic resonance imaging Right ventricle Ejection fraction
Online Access:	http://www.sciencedirect.com/science/article/pii/S1880427616300783

Similar Items

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Successful implantable cardioverter-defibrillator implantation through a communicating branch of the persistent left superior vena cava
by: Vineet Kumar, MD, et al.
Published: (2015-10-01)

First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia
by: Pal Abraham, MD, et al.
Published: (2015-01-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Molecular mechanisms of heart failure progression associated with implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias
by: Yukiomi Tsuji, MD, PhD, et al.
Published: (2014-08-01)

Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation
by: Atsushi Suzuki, MD, et al.
Published: (2015-06-01)

Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator
by: Kazuya Mizukami, MD, PhD, et al.
Published: (2017-06-01)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
by: Michele Murphy, MD, et al.
Published: (2016-11-01)

Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2017-02-01)

Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
by: Anita Rahmawati, MD, et al.
Published: (2016-04-01)

A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillatorKey Findings
by: Yuji Ishida, MD, PhD, et al.
Published: (2020-04-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

Successful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal
by: Mitsuhiro Fukata, MD, PhD, et al.
Published: (2017-09-01)

Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management
by: Malik Shehadeh, MD, et al.
Published: (2020-12-01)

Undetected ventricular fibrillation in a single-chamber implantable cardioverter-defibrillator: When the far-field channel sees more than the intraventricular channel
by: Milena Kubickova, MD, et al.
Published: (2016-07-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review
by: Mohammad Ali Akbarzadeh, MD, et al.
Published: (2017-02-01)

Ventricular Tachycardia Precipitated by Short-long-short Sequence in a Patient with Implantable-cardioverter Defibrillator
by: Diego Chemello, MD, et al.
Published: (2012-01-01)

T-wave oversensing during left ventricular pacing causing inappropriate defibrillation
by: Joshua Payne, MD, MPH, et al.
Published: (2017-10-01)

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
by: Sing-Chien Yap, MD, PhD, et al.
Published: (2015-05-01)

Current status of implantable defibrillator devices in patients with left ventricular dysfunction — The first report from the online registry database
by: Akihiko Shimizu, MD, et al.
Published: (2008-01-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Usefulness of a wearable cardioverter defibrillator combined with catheter ablation for ventricular tachyarrhythmia storms after a myocardial infarction: A case report
by: Yusuke Yoshikawa, MD, et al.
Published: (2015-08-01)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
by: Matthew F. Yuyun, MD, MPhil, PhD, et al.
Published: (2020-05-01)

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
by: Naomichi Matsumoto, MD, et al.
Published: (2010-01-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-02-01)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
by: Yoshimori An, MD, et al.
Published: (2017-02-01)

A broken lead to an open heart: implantable cardioverter defibrillator vegetations with lead fracture
by: George Horani, MD, et al.
Published: (2021-11-01)

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart syndrome
by: Justin G. Reeves, MD, et al.
Published: (2015-07-01)

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
by: Hirotaro Sugiyama, MD, et al.
Published: (2017-06-01)

A case of short-coupled premature ventricular beat-induced ventricular fibrillation with early repolarization in the inferolateral leads
by: Hidekazu Kondo, MD, et al.
Published: (2015-02-01)

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators
by: Daisuke Ishigaki, M.D., et al.
Published: (2016-12-01)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
by: Nobuhiro Nishii, MD, et al.
Published: (2017-08-01)

An effect of left ventricular hypertrophy on mild-to-moderate left ventricular diastolic dysfunction
by: Sharma Kattel, MD, et al.
Published: (2016-03-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
by: Ariel Vinas, MD, et al.
Published: (2021-02-01)